PROM2: A Potential Drug Target and Biomarker (G150696)

Target Name: PROM2

NCBI ID: G150696

PROM2

PROM2: A Potential Drug Target and Biomarker

Protein kinases are a family of enzymes that play a crucial role in cellular signaling. Prominin-related protein (PROM2) is a non-coding RNA-like protein that has been identified as a potential drug target and biomarker for various diseases. PROM2 has unique structural features that make it an attractive target for small molecule inhibitors. In this article, we will discuss the structure and function of PROM2, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Mechanism

PROM2 is a 198-amino acid protein with a calculated molecular mass of 21.1 kDa. It has a unique structure that consists of a 156-amino acid protein body and a 36-amino acid tail. The protein body has a single transmembrane region that is involved in protein-protein interactions and is responsible for the protein's stability. The tail region has a hinge region that allows for the formation of a dimeric complex with other proteins.

PROM2 is a non-coding RNA-like protein that is expressed in various tissues, including the brain, heart, and pancreas. It has been shown to play a role in cellular signaling by regulating the activity of several enzymes, including casein kinase (CK ), kinase B3 (IKB3), and DNA-protein binding proteins. PROM2 has also been shown to play a role in regulating the expression of genes involved in cell growth, apoptosis, and inflammation.

Potential Drug Target

PROM2 is a protein that can be targeted by small molecule inhibitors. Its unique structure and function as a non-coding RNA-like protein make it an attractive target for small molecule inhibitors. Several studies have shown that PROM2 can be inhibited by small molecules such as inhibitors of tyrosine phosphorylation, inhibitors of protein-protein interactions, and inhibitors of DNA-protein binding.

PROM2 has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in cell growth, differentiation, and inflammation. PROM2 has also been shown to play a role in the regulation of TGF-β signaling by regulating the activity of several enzymes, including the transcription factor SMAD2.

Potential Biomarkers

PROM2 has also been shown to be a potential biomarker for several diseases. Its unique structure and function as a protein with potential drug target make it an attractive target for diagnostic tests. Several studies have shown that PROM2 is involved in the regulation of cellular signaling pathways and has been used as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the potential benefits of PROM2 as a biomarker is its ability to be used in non-invasive diagnostic tests. Its small size and the fact that it is expressed in various tissues make it an attractive target for diagnostic tests that do not require a biopsy . PROM2 has also been shown to be involved in the regulation of cellular signaling pathways, making it an attractive target for diagnostic tests that are used to detect changes in cellular signaling.

Conclusion

PROM2 is a unique protein that has a non-coding RNA-like structure and plays a role in the regulation of cellular signaling pathways. Its potential as a drug target and biomarker makes it an attractive target for small molecule inhibitors. Its unique structure and function make it an attractive target for diagnostic tests that are non-invasive and can detect changes in cellular pathways. Further research is needed to fully understand the role of PROM2 in signaling

Protein Name: Prominin 2

The "PROM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PROM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets